News and Announcements
PeriCoach Granted Patent Protection in China
- Published August 05, 2016 3:26PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
3rd August 2016, ASX Announcement
Analytica Ltd (ASX: ATL), manufacturer of the PeriCoach® System has been granted patent protection (Patent No ZL201280018210.2) in the People’s Republic of China for the device’s unique pelvic floor sensing technology. It is estimated that there are nearly 227 million target women with urinary incontinence in China. This is the first of the PeriCoach patents to be granted in the major markets and is in line with the overall strategy for PeriCoach: to secure intellectual property protection for key geographies that have ageing populations, with increased awareness of urinary incontinence, and growing demand towards conservative treat solutions.
It has remained a top priority to ensure the PeriCoach becomes a global product, therefore Analytica has maintained its investment on intellectual protection in major markets around the world.
To view the full announcement, please click on the button below.
Company Updates
Capital Is Flowing – Just Not to Everyone: Inside Australia’s $1.8 Billion Q1 2026
Australia’s startup ecosystem opened 2026 with a number that demanded attention. In the first three months of the year, $1.8 billion was raised across 81 venture deals and 26 accelerator rounds. That makes Q1 2026 the strongest start to a year since the 2022 boom, up 63% on Q1 2025, and more than double the […]
The control layer for the electrified home
THE MARKET SHIFT Australian households have been pulled into a real-time energy market they never knowingly signed up for. Flat electricity tariffs are disappearing. In their place: dynamic, time-of-use pricing that changes depending on when power is consumed. Electricity is now cheapest when solar floods the grid in the middle of the day — and […]
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
Backed By Leading Investment Groups and Family Offices
